Literature DB >> 18631436

Genetic susceptibility of diabetic retinopathy.

Shrena Patel1, Haoyu Chen, Nicholas H Tinkham, Kang Zhang.   

Abstract

Diabetes continues to be a major source of -morbidity and mortality among working-age adults nationally and internationally. The microvascular complications of diabetes, including diabetic retinopathy, account for a major proportion of disease-associated morbidity and likely contribute to macrovascular complications. Although glycemic control contributes to -susceptibility for diabetic complications, some people with strict control develop these complications, whereas -others with poor control remain complication free. This suggests a genetic contribution to disease development. Although many genes and proteins of vascular growth have been studied in association with diabetic retinopathy, no definitive major predisposing genes or functional consequences of genetic variants have been identified for microvascular complications of the disease. In this article, we review the studies done on candidate genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18631436     DOI: 10.1007/s11892-008-0046-6

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  48 in total

1.  Polymorphisms of the aldose reductase gene and susceptibility to retinopathy in type 1 diabetes mellitus.

Authors:  A Demaine; D Cross; A Millward
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-12       Impact factor: 4.799

2.  Angiogenic pathways in diabetic retinopathy.

Authors:  Lloyd Paul Aiello
Journal:  N Engl J Med       Date:  2005-08-25       Impact factor: 91.245

Review 3.  Genetic linkage and association studies of Type I diabetes: challenges and rewards.

Authors:  L L Field
Journal:  Diabetologia       Date:  2002-01       Impact factor: 10.122

4.  Retinopathy as a predictor of other diabetic complications.

Authors:  A M El-Asrar; K A Al-Rubeaan; S A Al-Amro; O A Moharram; D Kangave
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

5.  Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy.

Authors:  Maria Enge; Mattias Bjarnegård; Holger Gerhardt; Erika Gustafsson; Mattias Kalén; Noomi Asker; Hans-Peter Hammes; Moshe Shani; Reinhardt Fässler; Christer Betsholtz
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

6.  Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications.

Authors:  Zongzhong Tong; Zhenglin Yang; Shrena Patel; Haoyu Chen; Daniel Gibbs; Xian Yang; Vincent S Hau; Yuuki Kaminoh; Jennifer Harmon; Erik Pearson; Jeanette Buehler; Yuhong Chen; Baifeng Yu; Nicholas H Tinkham; Norman A Zabriskie; Jiexi Zeng; Ling Luo; Jennifer K Sun; Manvi Prakash; Rola N Hamam; Stephen Tonna; Ryan Constantine; Cecinio C Ronquillo; SriniVas Sadda; Robert L Avery; John M Brand; Nyall London; Alfred L Anduze; George L King; Paul S Bernstein; Scott Watkins; Lynn B Jorde; Dean Y Li; Lloyd Paul Aiello; Martin R Pollak; Kang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

7.  Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study.

Authors:  M I Harris; R Klein; C C Cowie; M Rowland; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-08       Impact factor: 19.112

8.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

9.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

10.  Evaluation of AC(n) and C(-106)T polymorphisms of the aldose reductase gene in Brazilian patients with DM1 and susceptibility to diabetic retinopathy.

Authors:  Flávio Richeti; Renata Maria Noronha; Ricardo Temudo Lessa Waetge; José Paulo Cabral de Vasconcellos; Osías Francisco de Souza; Bianca Kneipp; Nilma Assis; Mylene Neves Rocha; Luís Eduardo Procópio Calliari; Carlos Alberto Longui; Osmar Monte; Monica Barbosa de Melo
Journal:  Mol Vis       Date:  2007-05-23       Impact factor: 2.367

View more
  8 in total

Review 1.  Genome-wide association studies: applications and insights gained in Ophthalmology.

Authors:  A Chandra; D Mitry; A Wright; H Campbell; D G Charteris
Journal:  Eye (Lond)       Date:  2014-06-27       Impact factor: 3.775

2.  Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development.

Authors:  Gi Liou; Ab El-Remessy; As Ibrahim; Rb Caldwell; Ym Khalifa; A Gunes; Jj Nussbaum
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-09

Review 3.  Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma.

Authors:  Kang Zhang; Liangfang Zhang; Robert N Weinreb
Journal:  Nat Rev Drug Discov       Date:  2012-06-15       Impact factor: 84.694

4.  Association of VEGF gene polymorphisms with diabetic retinopathy: a meta-analysis.

Authors:  Jian-Yang Gong; Ye-Huan Sun
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

Review 5.  Recent Update on the Role of Chinese Material Medica and Formulations in Diabetic Retinopathy.

Authors:  Sandeep Vasant More; In-Su Kim; Dong-Kug Choi
Journal:  Molecules       Date:  2017-01-04       Impact factor: 4.411

Review 6.  Candidate genes for proliferative diabetic retinopathy.

Authors:  Daniel Petrovič
Journal:  Biomed Res Int       Date:  2013-08-27       Impact factor: 3.411

7.  The role of NOS2A -954G/C and vascular endothelial growth factor +936C/T polymorphisms in type 2 diabetes mellitus and diabetic nonproliferative retinopathy risk management.

Authors:  Mihai Dumitru Porojan; Andreea Cătană; Radu A Popp; Dan L Dumitrascu; Cornelia Bala
Journal:  Ther Clin Risk Manag       Date:  2015-11-27       Impact factor: 2.423

Review 8.  Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.

Authors:  Ryan Lee; Tien Y Wong; Charumathi Sabanayagam
Journal:  Eye Vis (Lond)       Date:  2015-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.